Consen Bio

Guangzhou Konsen Bioscience Co., Ltd. was founded in 2001 by returned overseas students in Guangzhou Economic and Technological Development Zone, focusing on the research and development, production, and sales of blood purification technology and products. After more than 20 years of rapid and steady development, Konsen Bio has become a well-known brand in the industry. As a high-tech biomedical enterprise driven by technological innovation, Konsen Bio has always adhered to independent innovation. It is a National Intellectual Property Advantage Enterprise, holding more than 160 patented technologies, and has successfully developed 12 core medical products with independent intellectual property rights, including the gene-engineered recombinant protein A immunoadsorption column with world-advanced technology. Konsen Bio is committed to continuous expansion in blood purification technology. Its innovative technologies have extended the application of blood purification from hemodialysis to precise targeted removal, applicable to the treatment of critically ill patients with end-stage renal disease (ESRD), immune diseases, organ transplant rejection, severe liver disease, ICU, etc., providing products and services to more than 1,000 hospitals across the country. All technologies and products of Konsen Bio have completely independent intellectual property rights. The related core patents won the 22nd China Patent Award, and product sales have always ranked among the top in the market. In 2014, Konsen Bio successfully developed China's first gene-engineered recombinant protein A immunoadsorption product approved as a Class III medical device, with technology at the world's advanced level. It has unique efficacy for refractory severe immune diseases and organ transplant rejection, was listed in the Ministry of Science and Technology's "Innovative Medical Device Catalog (2018)", and won three provincial-level Science and Technology Progress Awards. The company's blood purification series products under development have performance reaching (and some indicators exceeding) the standards of similar products worldwide. Some products are expected to become the first medical device products in China and even globally. Konsen Bio has become one of the enterprises with the most comprehensive, deepest, and fastest industrial transformation in the field of blood purification adsorption in China. In 2019, Konsen Bio's new fully automated production line for hemodialysis concentrate/powder was completed and put into operation, with production capacity and automation level reaching a leading level, providing good experience and exemplary demonstration for promoting production automation and intelligence in the industry. Konsen Bio has successively undertaken more than 30 scientific and technological projects at various levels, participated in the formulation of multiple industry standards, and received qualifications such as "Guangdong Provincial Key Laboratory", "Guangdong Provincial Enterprise Technology Center", "Guangdong Provincial Engineering Technology Research Center", "Guangdong Provincial Specialized and Sophisticated Enterprise", "Guangdong Provincial Single Champion Enterprise", "Guangdong Provincial Innovative Enterprise", and "Guangdong Provincial Academician Workstation for Research and Application of Blood Purification Adsorption Products and Technology". It has also established long-term technical cooperation relationships with more than 40 universities, research institutions, and enterprises, including the Chinese Academy of Sciences and partners in the UK, US, Germany, Italy, etc. Adhering to the purpose of "Technological Innovation for Development, Integrity and Quality for Brand", and pursuing the goal of "Curing Diseases and Saving Patients, Benefiting Patients", Konsen Bio will always focus on the field of blood purification, adhere to the path of technological innovation, continuously increase research and development investment, develop more leading blood purification technologies and products, and expect to become one of the well-known brands in the industry in the near future. Konsen Bio is committed to becoming a pioneer in the field of blood purification!